Trial Outcomes & Findings for OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO (NCT NCT02819011)

NCT ID: NCT02819011

Last Updated: 2020-02-27

Results Overview

Hip sway (motion of hip joints in three dimensions) measured by wearable sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

44 participants

Primary outcome timeframe

baseline to 6 months

Results posted on

2020-02-27

Participant Flow

Participant milestones

Participant milestones
Measure
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study. Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
This group will be provided with a pair of New Balance 813 shoes for the duration of the study. Control: Subjects will be provided with a pair of New Balance 813 shoes
Overall Study
STARTED
22
22
Overall Study
COMPLETED
15
17
Overall Study
NOT COMPLETED
7
5

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study. Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study. Control: Subjects will be provided with a pair of New Balance 813 shoes
Total
n=44 Participants
Total of all reporting groups
Age, Continuous
73.7 years
STANDARD_DEVIATION 6.3 • n=99 Participants
75.6 years
STANDARD_DEVIATION 6.5 • n=107 Participants
74.7 years
STANDARD_DEVIATION 6.4 • n=206 Participants
Sex: Female, Male
Female
17 Participants
n=99 Participants
14 Participants
n=107 Participants
31 Participants
n=206 Participants
Sex: Female, Male
Male
5 Participants
n=99 Participants
8 Participants
n=107 Participants
13 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=99 Participants
2 Participants
n=107 Participants
4 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
20 Participants
n=99 Participants
20 Participants
n=107 Participants
40 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Region of Enrollment
United States
22 participants
n=99 Participants
22 participants
n=107 Participants
44 participants
n=206 Participants

PRIMARY outcome

Timeframe: baseline to 6 months

Population: Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data

Hip sway (motion of hip joints in three dimensions) measured by wearable sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)

Outcome measures

Outcome measures
Measure
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study. Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study. Control: Subjects will be provided with a pair of New Balance 813 shoes
Hip Sway Change From Baseline to 6 Months
Baseline
3.65 degree^2
Standard Deviation 3.22
3.75 degree^2
Standard Deviation 3.63
Hip Sway Change From Baseline to 6 Months
@6Month
2.15 degree^2
Standard Deviation 1.24
3.89 degree^2
Standard Deviation 2.15

PRIMARY outcome

Timeframe: baseline to 6 months

Population: Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data

Ankle sway (motion of ankle joint in three dimensions) measured by wearable inertial sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)

Outcome measures

Outcome measures
Measure
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study. Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study. Control: Subjects will be provided with a pair of New Balance 813 shoes
Ankle Sway Change From Baseline to 6 Months
Baseline
3.50 degree^2
Standard Deviation 3.74
3.21 degree^2
Standard Deviation 2.43
Ankle Sway Change From Baseline to 6 Months
@6Month
1.03 degree^2
Standard Deviation 0.69
3.56 degree^2
Standard Deviation 2.54

PRIMARY outcome

Timeframe: baseline to 6 months

Population: Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data

Center of Mass (COM) sway measured by wearable inertial sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)

Outcome measures

Outcome measures
Measure
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study. Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study. Control: Subjects will be provided with a pair of New Balance 813 shoes
Center of Mass (COM) Sway Change Baseline to 6 Months
Baseline
0.71 cm^2
Standard Deviation 0.50
0.85 cm^2
Standard Deviation 0.65
Center of Mass (COM) Sway Change Baseline to 6 Months
@6Month
0.32 cm^2
Standard Deviation 0.18
0.76 cm^2
Standard Deviation 0.54

SECONDARY outcome

Timeframe: 6 months

The adherence of participants to the prescribed Ankle-Foot Orthosis (AFO) plus walking shoes was quantified using the response to a self-reported question ("How many hours per day did you wear the prescribed footwear?").

Outcome measures

Outcome measures
Measure
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=14 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study. Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=13 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study. Control: Subjects will be provided with a pair of New Balance 813 shoes
Adherence (Hours Per Day to Wear Ankle-Foot Orthosis (AFO))
5.4 hours per day
Standard Deviation 3.3
5.6 hours per day
Standard Deviation 3.2

SECONDARY outcome

Timeframe: Baseline, 12 months

Population: Some participants in AFO and No AFO groups withdrew from study in 6 and 12 months. Generalized Estimating Equation Analysis can handle such missing data

Fall incidents during the study

Outcome measures

Outcome measures
Measure
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study. Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study. Control: Subjects will be provided with a pair of New Balance 813 shoes
Fall Incidents
Baseline
2.27 falls per year precedent
Standard Deviation 4.17
1.82 falls per year precedent
Standard Deviation 4.19
Fall Incidents
@12Month
0.80 falls per year precedent
Standard Deviation 1.27
0.94 falls per year precedent
Standard Deviation 1.25

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data

Concern for falling is quantified by Falls Efficacy Scale - International (FES-I) questionnaire. Scores range from minimum 16 (no concern about falling) to maximum 64 (severe concern about falling). Higher score indicate worse performance.

Outcome measures

Outcome measures
Measure
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study. Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study. Control: Subjects will be provided with a pair of New Balance 813 shoes
Concern for Falling Change Form Baseline to 6 Months
Baseline
32.8 score on a scale
Standard Deviation 10.7
33.3 score on a scale
Standard Deviation 11.5
Concern for Falling Change Form Baseline to 6 Months
@6Month
27.0 score on a scale
Standard Deviation 9.0
30.1 score on a scale
Standard Deviation 13.9

SECONDARY outcome

Timeframe: baseline to 6 months

Population: Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data

Physical activity level for 24 hours while wearing their own shoes compared to the walking shoes and compared to walking shoes plus Ankle-Foot Orthosis (AFO). To quantify physical activity, number of taken steps per day was monitored using a pendant wearable sensor called, PAMSys (Biosensics, MA, USA).

Outcome measures

Outcome measures
Measure
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study. Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study. Control: Subjects will be provided with a pair of New Balance 813 shoes
Physical Activity Level
Baseline
4017 number of steps per day
Standard Deviation 2008
3847 number of steps per day
Standard Deviation 3645
Physical Activity Level
@6Month
4872 number of steps per day
Standard Deviation 2657
4297 number of steps per day
Standard Deviation 2735

SECONDARY outcome

Timeframe: assessed at 1, 3, 6, and 12 months, month 12 reported

Number of participants with adverse events reported during the study. Adverse events was inquired at 1 months, 3 months, 6 months, 12 months after the baseline, and summed at 12 months. If the participant has at least one adverse event reported in any assessed time frame, the participant will be categorized as the participant with adverse event.

Outcome measures

Outcome measures
Measure
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study. Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study. Control: Subjects will be provided with a pair of New Balance 813 shoes
Number of Participants With Adverse Events
0 Participants
0 Participants

SECONDARY outcome

Timeframe: 6 months

The participants perceived usefulness of ease of use of wearing Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) based on questionnaires of A technology acceptance model (TAM). Perceived usefulness was assessed using two questions (i.e., "I feel more stable when standing," and "I feel more stable when walking"). Perceived ease of use was assessed using two questions (i.e., "Was easy to take on and off," and "Was comfortable to wear"). The Likert scale (6-point scale from 0-5) was used to quantify how much they disagreed with each statement, including "strongly disagree," "disagree," "somewhat disagree," "somewhat agree," "agree," and "strongly agree," respectively. In this paper, responses were only categorized as positive (3-5 points) or negative (0-2 points) attitudes towards the use of AFO plus walking shoes.

Outcome measures

Outcome measures
Measure
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=14 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study. Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
This group will be provided with a pair of New Balance 813 shoes for the duration of the study. Control: Subjects will be provided with a pair of New Balance 813 shoes
Percentage of Participants Who Found the Device Useful and Easy to Use
perceived usefulness
79 percentage of participants
Percentage of Participants Who Found the Device Useful and Easy to Use
perceived ease of use
93 percentage of participants

SECONDARY outcome

Timeframe: baseline, 6 months

Population: Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data

stride velocity measured in single-task walking with normal speed

Outcome measures

Outcome measures
Measure
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study. Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study. Control: Subjects will be provided with a pair of New Balance 813 shoes
Stride Velocity
Baseline
0.80 m/sec
Standard Deviation 0.23
0.81 m/sec
Standard Deviation 0.27
Stride Velocity
6 months
0.88 m/sec
Standard Deviation 0.27
0.88 m/sec
Standard Deviation 0.30

SECONDARY outcome

Timeframe: baseline, 6 months

Population: Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data

stride time measured in single task walking with normal speed

Outcome measures

Outcome measures
Measure
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study. Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study. Control: Subjects will be provided with a pair of New Balance 813 shoes
Stride Time
Baseline
1.27 seconds
Standard Deviation 0.18
1.24 seconds
Standard Deviation 0.21
Stride Time
6 months
1.25 seconds
Standard Deviation 0.23
1.21 seconds
Standard Deviation 0.18

SECONDARY outcome

Timeframe: baseline, 6 months

Population: Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data

stride length measured in single-task walking with normal speed

Outcome measures

Outcome measures
Measure
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study. Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study. Control: Subjects will be provided with a pair of New Balance 813 shoes
Stride Length
Baseline
0.98 meters
Standard Deviation 0.17
0.96 meters
Standard Deviation 0.22
Stride Length
6 months
1.05 meters
Standard Deviation 0.22
1.01 meters
Standard Deviation 0.27

Adverse Events

Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Prof.Bijan Najafi

Baylor College of Medicine

Phone: 17137987536

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: GT60